PSMD11 Antibodies

Santa Cruz Biotechnology features a diverse variety of PSMD11 monoclonal antibodies for research focused on understanding PSMD11 protein functions. PSMD11 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PSMD11, also known as 26S proteasome non-ATPase regulatory subunit 11, plays a critical role in the ubiquitin-proteasome pathway, which is essential for protein degradation and regulation of various cellular processes. PSMD11 is involved in maintaining cellular homeostasis and regulating the cell cycle, making it vital for normal cellular function and response to stress. Dysregulation of PSMD11 has been implicated in various diseases, including cancer, highlighting its importance as a target for therapeutic intervention. PSMD11 monoclonal antibodies enable researchers to explore protein expression patterns across different tissues and cellular compartments. PSMD11 monoclonal antibodies support investigations into cellular signaling mechanisms and protein-protein interactions. PSMD11 monoclonal antibodies facilitate detailed analysis of protein modifications and regulatory pathways. Santa Cruz Biotechnology monoclonal antibodies contribute to advancing scientific knowledge by supporting researchers in their pursuit of understanding complex biological systems and disease mechanisms.